MDM2

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

MDM2

Jun 2, 2024, 12:11 | Blog

New clinical data being presented at the ASCO from our ongoing KT-253 Phase 1 oncology trial - Kymera Therapeutics

Pearl Freier, Founder of Cambridge BioPartners, shared a post by Kymera Therapeutics on X/Twitter: "…

May 17, 2024, 04:29 | Insight

Rasoul Pourebrahim: New potential targets for preventing AML with p53 mutations

Rasoul Pourebrahim, Assistant Professor at MD Anderson Cancer Centre, shared on LinkedIn: "Our paper was…

May 12, 2024, 06:02 | Insight

Rasoul Pourebrahim: Our latest publication on studying mutant p53-driven Acute Myeloid Leukemia

Rasoul Pourebrahim, Assistant Professor at MD Anderson, made the following post on LinkedIn: "Our paper…

Mar 26, 2024, 00:22 | Opinion

Wafik S. El-Deiry: WIN Consortium in cancer personalized medicine MTB had well over 30 participants

Wafik S. El-Deiry shared on LinkedIn: "Today’s WIN Consortium in cancer personalized medicine MTB had well…

All: 4 Posts: 1 - 100